Publication:
Chemical and structural investigation of lipid nanoparticles: Drug-lipid interaction and molecular distribution

dc.contributor.authorSuranan Anantachaisilpen_US
dc.contributor.authorSiwaporn Meejoo Smithen_US
dc.contributor.authorAlongkot Treetongen_US
dc.contributor.authorSirapat Pratontepen_US
dc.contributor.authorSatit Puttipipatkhachornen_US
dc.contributor.authorUracha Rungsardthong Ruktanonchaien_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherThailand National Science and Technology Development Agencyen_US
dc.contributor.otherKing Mongkut's Institute of Technology Ladkrabangen_US
dc.date.accessioned2018-09-24T08:51:53Z
dc.date.available2018-09-24T08:51:53Z
dc.date.issued2010-03-19en_US
dc.description.abstractLipid nanoparticles are a promising alternative to existing carriers in chemical or drug delivery systems. A key challenge is to determine how chemicals are incorporated and distributed inside nanoparticles, which assists in controlling chemical retention and release characteristics. This study reports the chemical and structural investigation of γ-oryzanol loading inside a model lipid nanoparticle drug delivery system composed of cetyl palmitate as solid lipid and Miglyol 8121as liquid lipid. The lipid nanoparticles were prepared by high pressure homogenization at varying liquid lipid content, in comparison with the γ-oryzanol free systems. The size of the lipid nanoparticles, as measured by the photon correlation spectroscopy, was found to decrease with increased liquid lipid content from 200 to 160nm. High-resolution proton nuclear magnetic resonance (1H-NMR) measurements of the medium chain triglyceride of the liquid lipid has confirmed successful incorporation of the liquid lipid in the lipid nanoparticles. Differential scanning calorimetric and powder x-ray diffraction measurements provide complementary results to the1H-NMR, whereby the crystallinity of the lipid nanoparticles diminishes with an increase in the liquid lipid content. For the distribution of γ-oryzanol inside the lipid nanoparticles, the1H-NMR revealed that the chemical shifts of the liquid lipid in γ-oryzanol loaded systems were found at rather higher field than those in γ-oryzanol free systems, suggesting incorporation of γ-oryzanol in the liquid lipid. In addition, the phase-separated structure was observed by atomic force microscopy for lipid nanoparticles with 0% liquid lipid, but not for lipid nanoparticles with 5 and 10% liquid lipid. Raman spectroscopic and mapping measurements further revealed preferential incorporation of γ-oryzanol in the liquid part rather than the solid part of in the lipid nanoparticles. Simple models representing the distribution of γ-oryzanol and lipids (solid and liquid) inside the lipid nanoparticle systems are proposed. © 2010 IOP Publishing Ltd.en_US
dc.identifier.citationNanotechnology. Vol.21, No.12 (2010)en_US
dc.identifier.doi10.1088/0957-4484/21/12/125102en_US
dc.identifier.issn13616528en_US
dc.identifier.issn09574484en_US
dc.identifier.other2-s2.0-77949367139en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/28901
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=77949367139&origin=inwarden_US
dc.subjectChemical Engineeringen_US
dc.subjectChemistryen_US
dc.subjectEngineeringen_US
dc.subjectMaterials Scienceen_US
dc.titleChemical and structural investigation of lipid nanoparticles: Drug-lipid interaction and molecular distributionen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=77949367139&origin=inwarden_US

Files

Collections